Factbox-Major deals involving US drugmakers and biotechs over the past decade
June 9 (Reuters) - GSK has agreed to buy cancer drug developer Nuvalent for $10.6 billion in its big...
9th June, 2026
Covering equities, fixed income, derivatives, foreign exchange and macro‑economic policy, the Finance section draws on Global Banking & Finance Review’s market analysis and investment coverage. Articles provide data‑driven insights and strategies for investors, analysts and policymakers.
June 9 (Reuters) - GSK has agreed to buy cancer drug developer Nuvalent for $10.6 billion in its big...
9th June, 2026
June 9 (Reuters) - UK's blue-chip FTSE 100 slipped on Tuesday, weighed by shares of GSK after the he...
9th June, 2026
By Pavel Polityuk KYIV, June 9 (Reuters) - A freight tariff increase proposed by Ukraine's state rai...
9th June, 2026
FRANKFURT, June 9 (Reuters) - The Swiss pharmaceutical and diagnostics giant Roche said it is sticki...
9th June, 2026
June 9 (Reuters) - The UK's accounting regulator said on Tuesday it had launched an investigation in...
9th June, 2026

By Louise Rasmussen COPENHAGEN, June 9 (Reuters) - Cement maker Aalborg Portland, Denmark's largest...
9th June, 2026
June 9 (Reuters) - France's Technip Energies, Safran, Airbus and Tereos have agreed to form a joint...
9th June, 2026

By Florence Loeve PARIS, June 8 (Reuters) - Alta Ares, a French startup focusing on counter-drone te...
9th June, 2026
By Maria Martinez June 9 (Reuters) - German industrial production rose more than expected in April a...
9th June, 2026

June 9 (Reuters) - British homebuilder MJ Gleeson on Tuesday projected annual adjusted pretax profit...
9th June, 2026
June 9 (Reuters) - British homebuilder Bellway on Tuesday said customer demand has cooled after a po...
9th June, 2026
June 9 (Reuters) - British drugmaker GSK on Tuesday agreed to acquire U.S.-listed cancer drug develo...
9th June, 2026